Gilead Sciences, Inc. (GIS.DE) XETRA

105.24

-0.08(-0.08%)

Updated at January 14 05:35PM

Currency In EUR

Valuation

Market Cap115.69B
Enterprise Value132.41B
P/E Ratio18.66
PEG Ratio0.65
Price/Sales Ratio5.19
Price/Book Ratio7.03
Enterprise/Revenue5.8
Enterprise/EBITDA12.34

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.28
Operating Margin0.36

Management Effectiveness

Return On Assets0.14
Return On Equity0.41

Income Statement

Revenue28.75B
Revenue/Share23.4
Gross Profit22.5B
EBITDA4.43B
Net Income480M
Diluted EPS0.38

Balance Sheet

Total Cash7.35B
Total Cash/Share5.91
Total Debt24.94B
Total Debt/Equity1.16
Current Ratio1.45
Book Value Per Share17.26

Price History

52-Week Change17.65
52-Week High111.84
52-Week Low82.04
Moving Average 50 Days105.89
Moving Average 200 Days98.8

Statistics

Average Volume1,032
Shares Outstanding1.24B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate3.16
Trailing Annual Dividend Yield2.6
Payout Ratio0.49
Last Split Factor2:1
Last Split DateJanuary 28, 2013